Previous 10 | Next 10 |
2023-11-09 06:05:54 ET Summary LifeMD is experiencing strong subscriber retention rates and expects significant growth in the weight management drug segment. The company's telehealth operations and subsidiary, WorkSimpli, are also contributing to its success and expected to delive...
2023-11-08 21:02:05 ET LifeMD, Inc. (LFMD) Q3 2023 Earnings Conference Call November 08, 2023 04:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants S...
2023-11-08 16:59:43 ET More on LifeMD, Inc. LifeMD's Revival: The Phoenix Of The Health Industry LifeMD: I'm Buying The Commons And The 11.7% Yielding Preferreds LifeMD: A Derivative Beneficiary Of The Demand For Anti-Obesity Pharmaceuticals LifeMD, Inc. Q3 2...
Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues. Adjusted EPS of $0.08 per share compared with a loss of $0.03 in the year-ago period. Consolidated adjusted EBITDA increased to $2.8 million compared with a loss of $0.8 mi...
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeMD (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced today it's been ranked 166 on the Deloitte Technology Fast 500 ™, a prestigious ranking of the fastest-growing technology, media, telecommunications,...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
LifeMD Inc. (LFMD) is expected to report $-0.18 for Q3 2023
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2023 after the close of the U.S. financial markets on Novemb...
2023-10-16 10:21:18 ET Summary LifeMD, Inc.'s share price is soaring, once again. The company's focus on GLP-1 medications integration and primary care services exemplifies its commitment to comprehensive patient care. Its consistent increase in its share count could potential...
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Particle Health , an intelligent data platform that aggregates and delivers actionable patient data and insights to healthcare companies, and LifeMD , Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced the launch of private health insurance acceptance for its virtual primary care services, including weight management for medically qualified patients. Initially available in select states, the company plan...
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lot...